Real‐world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples

INTRODUCTION: Monitoring of factor IX (FIX) replacement therapy in haemophilia B relies on accurate coagulation assays. However, considerable interlaboratory variability has been reported for one‐stage clotting (OSC) assays. This study aimed to evaluate the real‐world, interlaboratory variability of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommer, Jurg M., Sadeghi‐Khomami, Ali, Barnowski, Christopher, Wikén, Margareta, Willemze, Annemieke J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318191/
https://www.ncbi.nlm.nih.gov/pubmed/32202380
http://dx.doi.org/10.1111/ijlh.13189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318191/
https://www.ncbi.nlm.nih.gov/pubmed/32202380
http://dx.doi.org/10.1111/ijlh.13189

Ejemplares similares